APJCP APJCP Submission APOCP APOCP Documents  
About the APJCP 
 Information for Authors
 APJCP Issues 
VOLUME 8, 2007  Issue Number 1 , 98-102
DownLoad : Kuttan 98-102.pdf
Inhibition of Chemically Induced Carcinogenesis by Drugs Used in Homeopathic Medicine
K B Hari Kumar et al
Homeopathy is considered as one modality for cancer therapy. However, there are only very few clinical
reports on the activity of the drugs, as well as in experimental animals. Presently we have evaluated the inhibitory
effects of potentized homeopathic preparations against N’-nitrosodiethylamine (NDEA) induced hepatocellular
carcinoma in rats as well as 3-methylcholanthrene-induced sarcomas in mice. We have used Ruta, Hydrastis,
Lycopodium and Thuja, which are commonly employed in homeopathy for treating cancer. Administration of
NDEA in rats resulted in tumor induction in the liver and elevated marker enzymes such as gamma-glutamyl
transpeptidase, glutamate pyruvate transaminase, glutamate oxaloacetate transaminase and alkaline phosphatase
in the serum and in liver. Concomitant administration of homeopathic drugs retarded the tumor growth and
significantly reduced the elevated marker enzymes level as revealed by morphological, biochemical and
histopathological evaluation. Out of the four drugs studied, Ruta 200c showed maximum inhibition of liver
tumor development. Ruta 200c and phosphorus 1M were found to reduce the incidence of 3-methylcholanthreneinduced
sarcomas and also increase the life span of mice harboring the tumours. These studies demonstrate that
homeopathic drugs, at ultra low doses, may be able to decrease tumor induction by carcinogen administration. At
present we do not know the mechanisms of action of these drugs useful against carcinogenesis.
Key Words: N’-Nitrosodiethylamine - hepatocellular carcinoma - sarcoma - homeopathy - Ruta - Thuja - Hydrastis- Lycopodium- phosphorus
APJCP Editorial Office : National Cancer Center, Korea. Tel : +82-31-920-1914 Fax : +82-31-920-1939
E-mail : apjcpedit@gmail.com
323 Ilsan-ro, Ilsandong-gu, Goyang-si Gyeonggi-do, 410-769, Republic of Korea
Copyright ⓒ National Cancer Center, Korea. All Rights Reserved.